CRLC Val d'Aurelle Paul-Lamarque
Montpellier, France
Hospital in Montpellier
πͺπΊ Euromedicine Park, 208 Av. des Apothicaires, 34090 Montpellier
About CRLC Val d'Aurelle Paul-Lamarque
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Institut du Cancer de Montpellier - Val d'Aurelle
8
Hoffmann-La Roche
7
UNICANCER
4
Centre Hospitalier Universitaire de NΔ«mes
3
Centre Leon Berard
3
Pfizer
2
Agendia
1
Agennix
1
Centre Oscar Lambret
1
Genentech, Inc.
1
Institut Cancerologie de l'Ouest
1
Clinical Trials at CRLC Val d'Aurelle Paul-Lamarque
During the past decade, CRLC Val d'Aurelle Paul-Lamarque conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
2003-09-01
2007-03-01
Completed
Imatinib in Adult Patients With Metastatic Ocular Melanoma
2005-12-01
2007-03-01
Terminated
13
Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma
2007-03-01
2008-03-01
Completed
10
A Study of Bevacizumab (Avastin) in Participants With Newly Diagnosed Locally Advanced Rectal Cancer
2007-10-23
2016-03-23
Completed
91
Stereotactic Body Radio Therapy (SBRT) for Early-stage Non Small Cell Lung Cancer (NSCLC)
2009-04-01
2013-03-01
Unknown status
120
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
2008-09-01
2019-12-01
Unknown status
1,200
Prospective Evaluation of the Resection Margins and the Ganglionic Status Using a Quality Standard Resection for Adenocarcinoma of the Head of the Pancreas
2008-08-01
2012-05-01
Completed
156
Impact of Chemotherapy on Ovarian Reserve in Young Women With Breast Cancer
2010-01-01
2014-04-01
Terminated
250
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CRLC Val d'Aurelle Paul-Lamarque" #1 sponsor was "Institut du Cancer de Montpellier - Val d'Aurelle" with 8 trials, followed by "Hoffmann-La Roche" with 7 trials
sponsored, "UNICANCER" with 4 trials sponsored, "Centre Hospitalier Universitaire de NΔ«mes" with 3 trials sponsored and "Centre Leon Berard"
with 3 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CRLC Val d'Aurelle Paul-Lamarque"
#1 collaborator was "National Cancer Institute, France" with 3 trials as a collaborator, "Novartis" with 2 trials as a collaborator, "Fondation ARC" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "Keyrus Biopharma" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at CRLC Val d'Aurelle Paul-Lamarque
According to Clinical.Site data, the most researched conditions in "CRLC Val d'Aurelle Paul-Lamarque" are
"Breast Cancer" (7 trials), "Adenocarcinoma" (2 trials), "Colorectal Cancer" (2 trials), "Parastomal Hernia" (2 trials) and "Adenocarcinoma of the Prostate" (1 trials). Many other conditions were trialed in "CRLC Val d'Aurelle Paul-Lamarque" in a lesser frequency.
Clinical Trials Intervention Types at CRLC Val d'Aurelle Paul-Lamarque
Most popular intervention types in "CRLC Val d'Aurelle Paul-Lamarque" are "Drug" (24 trials), "Procedure" (6 trials), "Other" (4 trials), "Radiation" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (4 trials), "Placebo" (3 trials), "Carboplatin" (2 trials), "Ipatasertib" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.
Clinical Trials Genders at CRLC Val d'Aurelle Paul-Lamarque
The vast majority of trials in "CRLC Val d'Aurelle Paul-Lamarque" are
26 trials for "All" genders, 9 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at CRLC Val d'Aurelle Paul-Lamarque
Currently, there are NaN active trials in "CRLC Val d'Aurelle Paul-Lamarque".
undefined are not yet recruiting,
3 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in CRLC Val d'Aurelle Paul-Lamarque,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in CRLC Val d'Aurelle Paul-Lamarque, 2 "Phase 1"
clinical trials were conducted, 14 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 6 trials that are defined as βNot Applicable".